MYND Life Sciences Inc. (MYNDF)
- Previous Close
0.0000 - Open
0.0450 - Bid 0.0130 x --
- Ask 0.1215 x --
- Day's Range
0.0450 - 0.0675 - 52 Week Range
0.0100 - 0.0723 - Volume
7,920 - Avg. Volume
521 - Market Cap (intraday)
2.398M - Beta (5Y Monthly) 1.37
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
MYND Life Sciences Inc., a life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States. It focuses on the analysis of psilocin and psilocybin extracts, and analogs. MYND Life Sciences Inc. is based in Port Coquitlam, Canada.
www.myndsciences.comRecent News: MYNDF
View MorePerformance Overview: MYNDF
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MYNDF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MYNDF
View MoreValuation Measures
Market Cap
2.39M
Enterprise Value
4.54M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
652.75k
Price/Book (mrq)
--
Enterprise Value/Revenue
6.35M
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-151.46%
Return on Equity (ttm)
--
Revenue (ttm)
1
Net Income Avi to Common (ttm)
-542.57k
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
497
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-658.04k